One of the most well-studied oncogenic roles of mortalin is its ability to bind cytoplasmic p53, thereby sequestering it in the cytoplasm, inhibiting its nuclear localization and tumor suppressive properties (Gestl and Anne Bottger, 2012; Elwakeel, 2022). Here, TP53 is linked to neoplasm.